1. Stanley MA. Epithelial cell responses to infection with human papillomavirus. Clin Microbiol Rev. 2012; 25:215–222.
Article
2. Zekan J, Skerlev M, Milić L, Karelovć D. Human papillomavirus-related diseases of the female lower genital tract: oncogenic aspects and molecular interaction. Coll Antropol. 2014; 38:779–786.
3. McLaughlin-Drubin ME, Münger K. The human papillomavirus E7 oncoprotein. Virology. 2009; 384:335–344.
Article
4. Oeckinghaus A, Hayden MS, Ghosh S. Crosstalk in NF-κB signaling pathways. Nat Immunol. 2011; 12:695–708.
Article
5. Ku JK, Kwon HJ, Kim MY, Kang H, Song PI, Armstrong CA, et al. Expression of Toll-like receptors in verruca and molluscum contagiosum. J Korean Med Sci. 2008; 23:307–314.
Article
6. Choi Y, Kim DH, Jin SY, Lee AY, Lee SH. Topical immunotherapy with diphenylcyclopropenone is effective and preferred in the treatment of periungual warts. Ann Dermatol. 2013; 25:434–439.
Article
7. Kim SY, Jung SK, Lee SG, Yi SM, Kim JH, Kim IH. New alternative combination therapy for recalcitrant common warts: the efficacy of imiquimod 5% cream and duct tape combination therapy. Ann Dermatol. 2013; 25:261–263.
Article
8. Vandermark ER, Deluca KA, Gardner CR, Marker DF, Schreiner CN, Strickland DA, et al. Human papillomavirus type 16 E6 and E 7 proteins alter NF-kB in cultured cervical epithelial cells and inhibition of NF-kB promotes cell growth and immortalization. Virology. 2012; 425:53–60.
Article
9. Valentine R, Dawson CW, Hu C, Shah KM, Owen TJ, Date KL, et al. Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation. Mol Cancer. 2010; 9:1.
10. Sloan E, Henriquez R, Kinchington PR, Slobedman B, Abendroth A. Varicella-zoster virus inhibition of the NF-κB pathway during infection of human dendritic cells: role for open reading frame 61 as a modulator of NF-κB activity. J Virol. 2012; 86:1193–1202.
Article